Specialized Medical Company (TADAWUL:4019)
Saudi Arabia · Delayed Price · Currency is SAR 16.65
-0.11 (-0.66%)
Jul 2, 2026, 3:18 PM AST
TADAWUL:4019 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, TADAWUL:4019 stock has a consensus rating of "Buy" and an average price target of SAR 26.30. The average 1-year stock price forecast is 57.96% higher than the current stock price, while the lowest is SAR 22.60 (+35.74%) and the highest is SAR 30.00 (+80.18%).
Price Target: SAR 26.30 (+57.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4019 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Nov '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
1.66B
from 1.54B
Increased by 8.10%
Revenue Next Year
1.78B
from 1.66B
Increased by 7.25%
EPS This Year
0.96
EPS Next Year
1.17
from 0.96
Increased by 21.23%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | ||
| Avg | 1.7B | ||
| Low | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.1% | ||
| Avg | 8.1% | ||
| Low | 8.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.96 | ||
| Avg | 0.96 | ||
| Low | 0.96 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 28.0% | |
| Avg | 21.2% | |
| Low | 14.5% |